The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Provocative tests with psychostimulant drugs in schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
The Pharmacological Basis for Therapeutics
JOHNS, M. E. (1981) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1981.00790410063020 · Cited by 1,993
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 943
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
Amphetamine Psychosis: A "Model" Schizophrenia Mediated by Catecholamines
SNYDER, S. H. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.61 · Cited by 587
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
(1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.197 · Cited by 556
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Scheel-Krüger, J. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90121-x · Cited by 400
The Experimental Reproduction of Amphetamine Psychosis
Bell, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200010020003 · Cited by 351
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320023004 · Cited by 310
FERRIS, R. M., TANG, F. L. M., & MAXWELL, R. A. (1972) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 301
Dextroamphetamine: Evaluation of Psychomimetic Properties in Man
Griffith, J. D. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200001001 · Cited by 270
Advances in Biochemical Psychopharmacology vol 1.
Goldstein, M. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480280095012 · Cited by 234
Biochemistry and Behavior: Some Central Actions of Amphetamine and Antipsychotic Drugs
Groves, P. M., & Rebec, G. V. (1976) · Annual Review of Psychology · doi:10.1146/annurev.ps.27.020176.000515 · Cited by 224
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Mackay, A. V. P. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.137.4.379 · Cited by 210
Methylphenidate, Dextroamphetamine, and Levamfetamine: Effects on Schizophrenic Symptoms
Janowsky, D. S. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030024003 · Cited by 205
CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs
McMillen, B. A. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90477-7 · Cited by 195
Brain catecholamines in schizophrenia — a good case for noradrenaline
Hornykiewicz, O. (1982) · Nature · doi:10.1038/299484a0 · Cited by 182
Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00427592 · Cited by 140
Biologic Heterogeneity and Psychiatric Research
Buchsbaum, M. S. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780110017001 · Cited by 137
The Dopamine Hypothesis: An Overview of Studies With Schizophrenic Patients
Haracz, J. L. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.438 · Cited by 129
Amphetamine Effects in Man: Paradoxical Drowsiness and Lowered Electrical Brain Activity (CNV)
Tecce, J. J., & Cole, J. O. (1974) · Science · doi:10.1126/science.185.4149.451 · Cited by 127
The actions of amphetamine on neurotransmitters: a brief review.
Moore, K. E. (1977) · PubMed · Cited by 124
Meta-analysis: Techniques, applications, and functions.
Strube, M., & Hartmann, D. P. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.1.14 · Cited by 113
CNS stimulants as tools in the study of schizophrenia
Angrist, B., & van Kammen, D. P. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80062-4 · Cited by 101
Hyporesponsivity of Chronic Schizophrenic Patients to Dextroamphetamine
Kornetsky, C. H. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770120029002 · Cited by 90
Methylphenidate challenge as a predictor of relapse in schizophrenia
Lieberman, J. A., Kane, J. M., Gadaleta, D. J., Brenner, R., LESSER, M., & Kinon, B. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.633 · Cited by 78
Self-citationAcute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate
Brown, W. A., Corriveau, D. P., & Ebert, M. H. (1978) · Psychopharmacology · doi:10.1007/bf00426906 · Cited by 74
FAWCETT, J. A. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750150055008 · Cited by 72
Guttmann, E., & Sargant, W. (1937) · BMJ · doi:10.1136/bmj.1.3984.1013 · Cited by 66
PROPORTIONAL MORTALITY AMONG VINYL-CHLORIDE WORKERS
Monson, R. R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91121-0 · Cited by 65
van Kammen, D. P., Docherty, J. P., & We, B. (1982) · PubMed · Cited by 63
In Freud's Shadow: Adler in Context
Lieberman, E. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1633 · Cited by 61
Nielsen, J. A., Chapin, D. S., & Moore, K. E. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90674-4 · Cited by 58
Pharmacological blockade of amphetamine effects in amphetamine dependent subjects
J�nsson, L. E. (1972) · European Journal of Clinical Pharmacology · doi:10.1007/bf00635797 · Cited by 57
Liddell, D. W., & Weil‐Malherbe, H. (1953) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.1.7 · Cited by 51
Amphetamine response and relapse risk after depot neuroleptic discontinuation
ANGRIST, B. M., Peselow, E. D., Rubinstein, M. E., Wolkin, A., & Rotrosen, J. (1985) · Psychopharmacology · doi:10.1007/bf00428187 · Cited by 49
Pennes, H. H. (1954) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195402000-00001 · Cited by 48
van Kammen, D. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030011002 · Cited by 42
Response of Depressed Patients to Methylamphetamine
Kiloh, L. G., Neilson, M. D., & Andrews, G. (1974) · The British Journal of Psychiatry · doi:10.1192/bjp.125.5.496 · Cited by 41
van Kammen, D. P., Bunney, W. E., Docherty, J. P., Dc, J., Post, R. M., Siris, P. A. S. G., Ebert, M. H., & Gillin, J. C. (1977) · PubMed · Cited by 37
Low neuroleptic serum levels in patients receiving fluphenazine decanoate
Tune, L. E., Creese, I., COYLE, J. T., Pearlson, G. D., & Snyder, S. H. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.80 · Cited by 35
Haloperidol and lithium blocking of the mood response to intravenous methylphenidate
Wald, D., Ebstein, R. P., & Belmaker, R. H. (1978) · Psychopharmacology · doi:10.1007/bf00426962 · Cited by 34
Janowsky, D. S. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770140079009 · Cited by 34
The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
Dommisse, C. S., Schulz, S. C., Narasimhachari, N., Blackard, W. G., & Hamer, R. M. (1984) · PubMed · Cited by 33
PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF INTRAVENOUS PERVITIN
Levine, J., Rinkel, M., & Greenblatt, M. (1948) · American Journal of Psychiatry · doi:10.1176/ajp.105.6.429 · Cited by 31
van Kammen, D. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030017003 · Cited by 29
Hauger, R. L., Hulihan-Giblin, B. A., Angel, I., Luu, M., Janowsky, A. J., Skolnick, P., & Paul, S. M. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90043-2 · Cited by 29
Amphetamine-Induced Dysphoria in Postmenopausal Women
Halbreich, U. M., Asnis, G. M., Ross, D. C., & Endicott, J. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.138.6.470 · Cited by 24
THE RESULTS OF EIGHTEEN MONTHS OF BENZEDRINE SULFATE THERAPY IN PSYCHIATRY
Davidoff, E., & Reifenstein, E. C. (1939) · American Journal of Psychiatry · doi:10.1176/ajp.95.4.945 · Cited by 23
Lack of Behavioral Supersensitivity to d-Amphetamine After Pimozide Withdrawal
van Kammen, D. P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780160057006 · Cited by 22
Shore, P. A., McMillen, B. A., Miller, H. H., Sanghera, M. K., Kiser, R. S., & German, D. C. (1979) · Elsevier eBooks · doi:10.1016/b978-1-4832-8363-0.50221-4 · Cited by 16
Comparison of oral and intravenous methylphenidate
Janowsky, D. S., Leichner, P. P., Clopton, P. L., et al. (1978) · Psychopharmacology · doi:10.1007/bf00428034 · Cited by 16
Fung, Y. K., & Uretsky, N. J. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb04783.x · Cited by 7
Cited by
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Metadata
- Authors
- Lieberman, J. A., Kane, J. M., & Alvir, J.
- Venue
- Psychopharmacology
- Published
- 1987-04
- Volume
- 91
- Issue
- 4
- Pages
- 415-433
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2038409107
- Cited by
- 532
- References
- 61
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.